Elin Richardsen

4.2k total citations
69 papers, 2.9k citations indexed

About

Elin Richardsen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elin Richardsen has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Elin Richardsen's work include Prostate Cancer Treatment and Research (19 papers), Cancer Immunotherapy and Biomarkers (14 papers) and MicroRNA in disease regulation (12 papers). Elin Richardsen is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Cancer Immunotherapy and Biomarkers (14 papers) and MicroRNA in disease regulation (12 papers). Elin Richardsen collaborates with scholars based in Norway, United States and United Kingdom. Elin Richardsen's co-authors include Lill‐Tove Busund, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Mehrdad Rakaee, Samer Al‐Saad, Sigurd M. Hald, Thomas K. Kilvær, Erna‐Elise Paulsen and Nora Ness and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Elin Richardsen

68 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elin Richardsen Norway 32 1.4k 1.0k 1.0k 852 805 69 2.9k
Andreas Pircher Austria 27 1.5k 1.0× 1.7k 1.6× 855 0.8× 931 1.1× 871 1.1× 103 3.4k
Sigve Andersen Norway 33 2.0k 1.4× 1.6k 1.6× 1.2k 1.2× 1.4k 1.6× 981 1.2× 80 3.9k
Shinichiro Kashiwagi Japan 28 1.7k 1.2× 617 0.6× 518 0.5× 819 1.0× 394 0.5× 196 2.6k
Vasiliki Pelekanou United States 30 1.8k 1.2× 720 0.7× 768 0.8× 607 0.7× 838 1.0× 75 3.0k
Iván Márquez‐Rodas Spain 25 3.0k 2.1× 1.3k 1.3× 778 0.8× 380 0.4× 1.2k 1.5× 120 4.1k
Anna Frolov United States 32 1.0k 0.7× 1.8k 1.7× 1.3k 1.3× 753 0.9× 426 0.5× 55 3.6k
Michael Bergqvist Sweden 27 873 0.6× 1.1k 1.1× 686 0.7× 579 0.7× 384 0.5× 112 2.5k
Zaoqu Liu China 32 1.2k 0.9× 1.5k 1.4× 1.2k 1.2× 1.1k 1.3× 826 1.0× 142 3.4k
Mariacarmela Santarpía Italy 28 1.3k 0.9× 1.1k 1.0× 1.1k 1.1× 629 0.7× 317 0.4× 118 2.4k
Bo Dai China 32 1.1k 0.8× 1.4k 1.4× 1.3k 1.3× 1.0k 1.2× 580 0.7× 144 3.3k

Countries citing papers authored by Elin Richardsen

Since Specialization
Citations

This map shows the geographic impact of Elin Richardsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elin Richardsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elin Richardsen more than expected).

Fields of papers citing papers by Elin Richardsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elin Richardsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elin Richardsen. The network helps show where Elin Richardsen may publish in the future.

Co-authorship network of co-authors of Elin Richardsen

This figure shows the co-authorship network connecting the top 25 collaborators of Elin Richardsen. A scholar is included among the top collaborators of Elin Richardsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elin Richardsen. Elin Richardsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knutsen, Tore, Tom Wilsgaard, Anne Elise Eggen, et al.. (2024). Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study. Acta Oncologica. 63. 154–163. 1 indexed citations
2.
Aarsæther, Erling, Tore Knutsen, Sigve Andersen, et al.. (2023). The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy. European Urology Open Science. 53. 6–15. 2 indexed citations
3.
Richardsen, Elin, Sigve Andersen, Samer Al‐Saad, et al.. (2019). Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer. Scientific Reports. 9(1). 10662–10662. 28 indexed citations
4.
Rakaee, Mehrdad, Simin Jamaly, Erna‐Elise Paulsen, et al.. (2019). Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry. Neoplasia. 21(3). 282–293. 119 indexed citations
5.
Richardsen, Elin, Sigve Andersen, Mehrdad Rakaee, et al.. (2019). MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer. Scientific Reports. 9(1). 386–386. 46 indexed citations
6.
7.
Rakaee, Mehrdad, Thomas K. Kilvær, Elin Richardsen, et al.. (2018). Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non–small cell lung cancer. Human Pathology. 79. 188–198. 54 indexed citations
8.
Andersen, Maria, Guro F. Giskeødegård, Elin Richardsen, et al.. (2018). Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma. Scientific Reports. 8(1). 14269–14269. 56 indexed citations
9.
Andersen, Sigve, Elin Richardsen, Mehrdad Rakaee, et al.. (2017). Expression of phosphatase of regenerating liver (PRL)-3, is independently associated with biochemical failure, clinical failure and death in prostate cancer. PLoS ONE. 12(11). e0189000–e0189000. 2 indexed citations
10.
11.
Hald, Sigurd M., Mehrdad Rakaee, Iñigo Martínez, et al.. (2017). LAG-3 in Non–Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival. Clinical Lung Cancer. 19(3). 249–259.e2. 58 indexed citations
12.
Nordby, Yngve, Elin Richardsen, Mehrdad Rakaee, et al.. (2017). High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Scientific Reports. 7(1). 43378–43378. 57 indexed citations
13.
Paulsen, Erna‐Elise, Thomas K. Kilvær, Mehrdad Rakaee, et al.. (2016). Assessing PDL-1 and PD-1 in Non–Small Cell Lung Cancer: A Novel Immunoscore Approach. Clinical Lung Cancer. 18(2). 220–233.e8. 72 indexed citations
14.
Andersen, Sigve, Nora Ness, Yngve Nordby, et al.. (2016). Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome. Scientific Reports. 6(1). 33114–33114. 32 indexed citations
15.
Andersen, Sigve, Elin Richardsen, Tom Dønnem, et al.. (2016). Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study. Scientific Reports. 6(1). 36573–36573. 14 indexed citations
16.
Dønnem, Tom, Sigurd M. Hald, Erna‐Elise Paulsen, et al.. (2015). Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non–Small Cell Lung Cancer. Clinical Cancer Research. 21(11). 2635–2643. 252 indexed citations
17.
Richardsen, Elin, Nora Ness, Samer Al‐Saad, et al.. (2015). The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer. American Journal Of Pathology. 185(10). 2722–2730. 31 indexed citations
18.
Andersen, Sigve, Samer Al‐Saad, Yury Kiselev, et al.. (2014). Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival. PLoS ONE. 9(9). e105038–e105038. 63 indexed citations
19.
Richardsen, Elin, Sveinung Wergeland Sørbye, John Crowe, Jialin Yang, & Lill‐Tove Busund. (2009). Expression of M-CSF and CSF-1R is correlated with histological grade in soft tissue tumors.. PubMed. 29(10). 3861–6. 11 indexed citations
20.
Richardsen, Elin, et al.. (2008). The prognostic impact of M‐CSF, CSF‐1 receptor, CD68 and CD3 in prostatic carcinoma. Histopathology. 53(1). 30–38. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Pircher Breakdown of academic impact, for papers by Sigve Andersen Breakdown of academic impact, for papers by Shinichiro Kashiwagi Breakdown of academic impact, for papers by Vasiliki Pelekanou Breakdown of academic impact, for papers by Iván Márquez‐Rodas Breakdown of academic impact, for papers by Anna Frolov Breakdown of academic impact, for papers by Michael Bergqvist Breakdown of academic impact, for papers by Zaoqu Liu Breakdown of academic impact, for papers by Mariacarmela Santarpía Breakdown of academic impact, for papers by Bo Dai
Rankless by CCL
2026